Navigation Links
Bausch & Lomb Appoints Global Vision Care and North American Vision Care Presidents
Date:5/11/2009

ROCHESTER, N.Y., May 11 /PRNewswire/ -- Bausch & Lomb, the global eye health company, has named Peter Valenti III as corporate vice president and global president, Vision Care, effective July 1.

He joined Bausch & Lomb in January 2009 as president, North America, Vision Care. Before being named to that role, Mr. Valenti served as vice president and general manager, Surgical Devices (U.S.), for Covidien, where he led the U.S. sales and marketing strategy for the $1 billion product portfolio from 2007 to 2008.

Prior, he spent 12 years with Johnson & Johnson in a variety of U.S. and international roles across consumer, pharmaceutical and device businesses. These included positions as vice president, Global Strategy, and vice president, U.S. Marketing, both in Vision Care, and as the lead on the marketing/marketing services organization design for J&J's acquisition of Pfizer Consumer Healthcare. He has also held brand management roles with Procter & Gamble Co. He holds an MBA from the Johnson School of Management at Cornell University, and a bachelor's degree from the University of Connecticut.

Mr. Valenti replaces Stuart Heap, who has chosen to step down from his current role with Bausch & Lomb for personal reasons effective June 30. Mr. Heap will remain an active strategic advisor to the company.

"Pete possesses a mix of deep leadership experience, healthcare and eye health expertise, and has already made significant contributions to helping grow the B&L business during his brief tenure. I'm excited about the future for Vision Care under his leadership," said Gerald M. Ostrov, chairman and CEO, Bausch & Lomb. "At the same time, we thank Stuart for his significant contributions to the company as he chooses to spend more time with his family."

In conjunction with Mr. Valenti's transition to his new role, the company has named Steven F. Robins as president, North America, Vision Care.

Mr. Robins joins B&L with approximately two decades of consumer healthcare experience at leading companies such as Johnson & Johnson, Pfizer and Warner Lambert. Most recently, he was general manager, Johnson & Johnson Consumer Healthcare Canada, and a vice president of the Johnson & Johnson Consumer Group, with responsibility for a number of well-known health and beauty brands such as Listerine, Reach, Band-Aid, Stayfree and Purell. Prior, he held marketing and category management leadership positions with Pfizer Inc., and product management positions with Warner Lambert Company's consumer healthcare group. He began his career at Young & Rubicam, the global advertising agency. He holds a bachelor's degree from Bates College.

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for people around the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.


'/>"/>
SOURCE Bausch & Lomb
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision Care
2. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
3. Bausch & Lomb Survey Shows People with Astigmatism Unaware of Contact Lens Options
4. Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development
5. Bausch & Lomb Launches Multi-Tiered U.S. Consumer Education Initiative to Raise Awareness of Presbyopia
6. Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide See a New You
7. VIDEO from Medialink and Bausch & Lomb: Bausch & Lomb Partners With Visual Therapy to Help Women Nationwide See a New You
8. Bausch & Lomb Japan Names Mitsuo Hirose as Chairman
9. Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
10. WorldHeart Appoints David Pellone Chief Financial Officer
11. Novo Nordisk Appoints New Leader of North American Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... BSI and Brenntag Canada have been appointed by Chr. ... of their natural fruits and beverage colorants effective November 1, 2016. ... our Life Sciences product portfolio,” said Steve Brauer, President of Brenntag Specialties, Inc. “Representing ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... Great Point Partners ("GPP") portfolio company, today announced it has acquired the ... TCS was previously a subsidiary of Chiltern International and focuses on ...
(Date:12/5/2016)... ... ... The new knee compression sleeves come as a pair which will provide ... lifting and any sport that requires knee compression or protection from the demands ... higher quality knee sleeve performance. Firstly it is made out of premium 7mm thick ...
(Date:12/5/2016)... OH (PRWEB) , ... December 05, 2016 , ... ... engineering solution called the CardioQuick Patch® significantly improves the reproducibility and accuracy of ... in various healthcare settings. , Over the last 60 years, studies have ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... "Best Surgical Body Shaping" at the 2016 Anti-Aging & Beauty Awards ... , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings together ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... SAN DIEGO , Dec. 3, 2016 Johnson ... filed on behalf of purchasers of Zimmer Biomet Holdings, Inc. ... September 7, 2016 through October 31, 2016 (the "Class Period"). ... It designs, manufactures, and markets orthopaedic reconstructive products, such as ... ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology: